浙江医药

- 600216

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
单位:元   
浙江医药(600216) 利润表
报告期2008-06-302008-03-312007-12-312007-09-30
一、主营业务收入2,039,819,198806,496,1202,208,825,5911,527,624,586
折扣与折让0000
主营业务收入净额2,039,819,198806,496,1202,208,825,5911,527,624,586
主营业务成本1,169,655,841558,181,9121,863,843,5541,331,936,060
主营业务税金及附加9,002,7422,569,5909,199,9147,524,082
二、主营业务利润861,160,615245,744,618335,782,123188,164,444
其他业务利润0000
存货跌价损失0000
营业费用114,842,95057,362,61580,126,79649,174,192
管理费用109,823,93048,248,24689,282,14266,286,183
财务费用75,555,68036,268,554106,619,80676,019,267
三、营业利润546,486,11386,323,09435,371,3437,461,060
投资收益12,991,12612,969,41448,924,2005,111,342
补贴收入0000
营业外收入3,662,8421,241,12710,797,4853,894,746
营业外支出9,324,3692,418,5706,678,0933,647,206
以前年度损益调整0000
营业外收支净额-5,661,527-1,177,4424,119,393247,540
四、利润总额553,815,71398,115,06788,336,06712,819,943
所得税135,915,92321,122,12633,387,0148,764,325
财政返还0000
少数股东权益826,903-76,053-1,655,926-1,737,452
购买日前净利润0000
未确认的投资损失0000
五、净利润417,072,88777,068,99356,604,9785,793,070
年初未分配利润0000
调整以前年度损益0000
盈余公积转入0000
住房周转金转入0000
其他转入0000
六、可分配利润0000
提取法定盈余公积0000
提取法定公益金0000
职工奖金福利0000
提取储备基金0000
提取企业发展基金0000
七、可供股东分配的利润0000
应付优先股股利0000
提取任意盈余公积金0000
应付普通股股利0000
转作股本的普通股股利0000
八、未分配利润0000
点击查看全部数据内容 返回页顶